EASTERLY INVESTMENT PARTNERS LLC

Position in PCRX — Pacira BioSciences, Inc.

CIK 1766150 BEVERLY, MA

Back to PCRX Full portfolio

Position in PCRX

as of Jun 30, 2026 · filed Jul 23, 2026 Compact

Position Value

$8,550,172

+$982,472 QoQ

Shares Held

337,019

+0.6% QoQ

Ownership

0.845%

of shares outstanding

% of Portfolio

0.45%

of 13F equity value

Holder Rank

#27

of 254 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in PCRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

EASTERLY INVESTMENT PARTNERS LLC holds $12,776,061 across 4 Drug Manufacturers - Specialty & Generic names. PCRX ranks #1 (66.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PCRX	Pacira BioSciences, Inc. This page	337,019	$8,550,172
2	LNTH	Lantheus Holdings, Inc.	15,819	$1,754,959
3	COLL	Collegium Pharmaceutical, Inc	44,231	$1,601,162
4	PBH	Prestige Consumer Healthcare Inc.	18,400	$869,768

All Filings in PCRX

Export CSV

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$8,550,172	337,019	+0.6%	Shares	Sole	2026-07-23
2026-03-31	$7,567,700	334,854	+33.0%	Shares	Sole	2026-05-11
2025-12-31	$6,517,981	251,854	+1.1%	Shares	Sole	2026-02-10
2025-09-30	$6,419,538	249,109	+46.5%	Shares	Sole	2025-11-12
2025-06-30	$4,064,696	170,071	+51.6%	Shares	Sole	2025-07-29
2025-03-31	$2,787,449	112,171	+6.2%	Shares	Sole	2025-05-02
2024-12-31	$1,990,464	105,651	-21.4%	Shares	Sole	2025-02-12
2024-09-30	$2,023,984	134,484	+27.4%	Shares	Sole	2024-11-01
2024-06-30	$3,019,957	105,556	+33.1%	Shares	Sole	2024-07-25
2024-03-31	$2,317,759	79,321	+43.1%	Shares	Sole	2024-05-03
2023-12-31	$1,870,680	55,444	+46.5%	Shares	Sole	2024-02-14
2023-09-30	$1,161,238	37,850	—	Shares	Sole	2023-11-13
No filing history on record for this holder in this stock.